Business Directory, Press Releases, Jobs, Products, Services, Articles
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | News on Your Site

Press Releases

The Hamner Institutes for Health Sciences

Press Release

Receive press releases from The Hamner Institutes for Health Sciences: By Email RSS Feeds:

The Hamner Institutes Reappoints Dr. William Greenlee as President and CEO

Institute’s Fourth President Receives Five-Year Extension from Board of Directors.

Research Triangle Park, NC, September 07, 2012 --( The Hamner Institutes for Health Sciences ( has announced that Dr. William Greenlee has been reappointed as president and CEO of the nonprofit research organization for a five-year term. Greenlee is the visionary leader behind the re-positioning of The Hamner as a multi-disciplinary, integrated, translational research center that features globally recognized platforms in chemical and drug safety. He has led The Hamner and its predecessor, CIIT, as president and CEO since 1999.

Under Greenlee’s guidance, The Hamner has fostered and expanded public-private partnerships, highlighted by a joint institute for drug safety sciences with the University of North Carolina at Chapel Hill and earlier this year the announcement of the Research Triangle Park Collaboration Consortium with Alexandria Real Estate Equities, Inc. The Hamner is committed to bringing together North Carolina’s leading research institutions in transformative partnerships that will strengthen the Research Triangle Park as a world-leading center for life sciences innovation and technology development.

“The Hamner is backed by 38 years of scientific discovery and research findings which have led to the improvement of human health, and we plan much more in the future under Dr. Greenlee’s continuing excellent leadership,” said Dr. Charles Hamner, board chairman. “I am excited about the efforts we already have underway, and I look forward to contributing in whatever way possible toward bringing The Hamner vision into fruition.”

“It is an honor to work with Dr. Greenlee and play a key role in efforts for The Hamner to establish and develop new initiatives that will lead to advancements in the treatment of human diseases,” said Dr. John Dent, board vice chairman and retired senior vice president of GlaxoSmithKline Consumer Healthcare R&D. “The accomplishments The Hamner already has achieved are impressive, and we have great potential to add to that legacy. With the drive and determination of Dr. Greenlee and other leaders, I am sure we can accomplish this mission.”

“I am honored to receive the support of The Hamner board for another term,” said Greenlee. “This vote of confidence will ensure that our road map for The Hamner remains firmly on a path toward becoming a global leader in translational life sciences research, innovation and training.”

New Media Content:
- The Hamner’s Twitter page

- The Hamner’s LinkedIn page

- Greenlee’s honors include serving as president of the Society of Toxicology and receiving the Benjamin Rush Award from Dickinson College, which honors exceptional leaders in business or government who uphold humanistic values. A fellow of the Academy of Toxicological Sciences, he is adjunct professor at the Department of Environmental and Molecular Toxicology at NC State University in Raleigh. For a full bio, visit

About The Hamner Institutes for Health Sciences:
The Hamner Institutes for Health Sciences is a nonprofit translational biomedical research institute dedicated to bettering human health through innovative science. The Hamner – together with academic, corporate and government partners – works to bring improved medicines from bench to bedside. The Hamner, located on an open, multidisciplinary campus in North Carolina’s Research Triangle Park, builds upon 35 years of research in toxicology; drug and chemical safety; rare, orphan and neglected diseases; and more. Novel technologies currently being developed include in silico models for predictive toxicology, in vitro models that utilize human cells or cell lines to evaluate perturbations of cellular responses, and in vivo models to elucidate genes that play a role in susceptibility to drug-induced toxicities. For more information, visit

Hamner Media Contact:
Erin Smith
MMI Public Relations
(919) 233-6600
Contact Information
The Hamner Institutes for Health Sciences
Patty Briguglio

Click here to view the list of recent Press Releases from The Hamner Institutes for Health Sciences
Promote Your Business